BioNTech SE Sponsored ADR
(NASDAQ: BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

116.160 -

-3.180 (-2.66%)
Range 114.610 - 117.700   (2.70%)
Open 117.430
Previous Close 119.340
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 909,016
Value 86,006,206
Remark -
Delayed prices. Updated at 29 Jan 2026 09:15.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis